Press release
Conbercept Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports
Conbercept Market SizeAccording to new survey, global Conbercept market is projected to reach US$ 273.6 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29M16036/Global_Conbercept_Market_Research_Report_2023
Mechanism of Action: Conbercept is designed to block the activity of vascular endothelial growth factor (VEGF), a protein that plays a crucial role in the development of abnormal blood vessels in the retina. By inhibiting VEGF, Conbercept helps reduce the growth of these abnormal blood vessels.
Administration: Conbercept is typically administered through intravitreal injection, meaning it is injected directly into the eye.
Approved Indications: Conbercept has received regulatory approval in some countries for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and other retinal vascular diseases.
Manufacturer: Conbercept is produced by Chengdu Kanghong Biotech Co., Ltd., a biopharmaceutical company based in China.
Growing Incidence of Retinal Diseases: The prevalence of retinal diseases, such as age-related macular degeneration and diabetic retinopathy, has been increasing globally. This trend has driven the demand for effective treatments like Conbercept.
Expansion of Market Access: Conbercept has gained regulatory approval in several countries, contributing to its market expansion. The availability of Conbercept for patients in different regions has likely influenced market trends.
Competition in the Anti-VEGF Market: The market for anti-VEGF drugs, including Conbercept, is competitive. Other drugs in this class, such as ranibizumab and aflibercept, also play a significant role in the management of retinal diseases.
Research and Development: Ongoing research and development efforts in the field of ophthalmology may lead to the introduction of new therapies or improvements in existing treatments, impacting the market dynamics for Conbercept.
Healthcare Infrastructure and Reimbursement Policies: The accessibility of Conbercept and other similar drugs can be influenced by factors such as healthcare infrastructure, reimbursement policies, and economic considerations in different regions.
By Type
• API
• Preperation
By Application
• nAMD
• pmCNV
• DME
Key Players
Kanghong Pharmaceutical
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-29M16036/global-conbercept
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Conbercept Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports here
News-ID: 3482607 • Views: …
More Releases from Valuates Reports
Power Supply for PC Gaming Market Research Report | Valuates Reports
Power Supply for PC Gaming Market Size
Global PC Power Supply market is projected to reach US$ 2402.7 million in 2029, increasing from US$ 2854 million in 2022, with the CAGR of -2.4% during the period of 2023 to 2029.
View Sample Report
https://reports.valuates.com/request/sample/QYRE-Auto-22Y14254/Global_Power_Supply_for_PC_Gaming_Market_Research_Report_2023
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Power Supply for PC Gaming market with…
Portable Stages Market: Size, Share, Growth, Analysis, Key Players, Revenue, Gro …
Portable Stages Market
A portable stage is an easy transportable platform generally made of aluminum truss and plywood or toughened glass set up indoor as well as outdoor.
The global Portable Stages market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Portable Stages is estimated to increase from $ million in…
Global and India Architectural and Furniture Hardware Market Size, Revenue, Insi …
Global and India Architectural and Furniture Hardware Market Size
The global Architectural and Furniture Hardware revenue was US$ 29920 million in 2022 and is forecast to a readjusted size of US$ 43420 million by 2029 with a CAGR of 5.4% during the forecast period (2023-2029).
View Sample Report
https://reports.valuates.com/request/sample/QYRE-Auto-36J16037/Global_and_India_Architectural_and_Furniture_Hardware_Market_Report_Forecast_2023_2029
Report Scope
Architectural and Furniture Hardware market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in…
AI Vulnerability Scanning Market: Size, Share, Growth, Analysis, Key Players, Re …
AI Vulnerability Scanning Market Size
In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12L15782/Global_AI_Vulnerability_Scanning_Market_Research_Report_2023
AI Vulnerability Scanning Market Trends
The growing use of AI technology across a range of industries, which also raises the risk of vulnerabilities and cyber attacks, is driving the market for AI vulnerability scanning. AI…
More Releases for Conbercept
Retinoblastoma Market is Projected to Boost at a Moderate Growth Rate by 2032 - …
The Retinoblastoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Retinoblastoma market dynamics.
DelveInsight's "Retinoblastoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of Retinoblastoma, historical and forecasted epidemiology as well as the Retinoblastoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom)…
How Novartis dominates the Age Related Macular Degeneration (AMD) Market
AMD is a leading cause of blindness in the around the globe, especially in the US. It occurs when the macula, the part of the eye that helps with central vision, slowly deteriorates. The disease affects 1 in 10 people over the age of 55, and as the population ages, the number of people with AMD is only going to increase. There is no cure for AMD, but there are…
2020 Latest Diabetic Retinopathy Market Expected to Grow to $8.6B at a CAGR of 9 …
The study includes analysis of the Diabetic Retinopathy Market, with their company profiles, recent developments, and the key market strategies. Diabetic Retinopathy Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. Diabetic Retinopathy Market report contains emerging players analyze data including competitive situations, sales, revenue and market share of top…
Global and China Drugs for Treatment of Age-related Macular Degeneration Researc …
The global Drugs for Treatment of Age-related Macular Degeneration market was valued at USD 64.83 Billion in 2015, and is projected to reach USD 90 Billion by 2021, at a CAGR of 6.78% between 2016 and 2021. Aging population leads to increase the prevalence of AMD, polypharmacy rates rise, the expected drugs enter the market which is studying, and the market quickly absorb those drugs.
This report studies Drugs for Treatment…
Global and China Drugs for Treatment of Age-related Macular Degeneration Market …
This report on Global and China Drugs for Treatment of Age-related Macular Degeneration market is a research study that is meant to armor existing and emerging players to gain shares. It does so by presenting a comprehensive analysis of the market in terms of revenue (US$ Mn), and also includes a figurative forecast estimation, both for the Global and China as well as regional markets. The report contains an elaborate…
Age-Related Macular Degeneration Treatment Drugs Market to Reach US$90 bn by 202 …
The report analyzes the historical as well as the current performance of this market, highlighting the major market trends.
The research report is titled “China, India, US And Japan Drugs For Treatment Of Age-Related Macular Degeneration Research Report To 2020.”
According to this study, the global market for age-related macular degeneration treatment drugs is estimated to rise at a CAGR of 6.78% during the period from 2016 to 2021 and increase…
